Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC

BSE3154.75-5.2 (-0.16 %)

PREV CLOSE ( ) 3159.95

OPEN PRICE ( ) 3180.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1590

TODAY'S LOW / HIGH ( )3120.85 3217.10

52 WK LOW / HIGH ( )1924.3 3515.95

NSE3144.20-18.2 (-0.58 %)

PREV CLOSE( ) 3162.40

OPEN PRICE ( ) 3175.00

BID PRICE (QTY) 3144.20 (87)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 115563

TODAY'S LOW / HIGH( ) 3120.40 3220.00

52 WK LOW / HIGH ( )1921 3515.7

Chairman	Renu Sud Karnad
Managing Director	Bhushan Akshikar
Company Secretary	Ajay Nadkarni
Non Executive Director	S Williams
Non Executive Independent Director	Manu Anand Sunita Maheshwari P R Somasundaram Anup Wadhawan
Whole Time Director	Juby Chandy

Incorporation Year : 13-11 1924

Registered Office :

Address : Gsk House, Dr. Annie Besant Road,Worli, Mumbai,
Maharashtra-400030 .

Phone : 022-24959595

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE